To Home Page
Hawaii High Intensity Drug Trafficking Area Drug Market Analysis 2010
Publication Date: May 2010
Document ID: 2010-R0813-010
Archived on: September 1, 2011. This document may contain dated information. It
remains available to provide access to historical materials.
This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program
for preparation of annual assessments depicting drug trafficking trends and developments
in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited
in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources
within those boundaries.
Your questions, comments, and suggestions for future subjects are welcome at
any time. Addresses are provided
at the end of the page.
List of Figures
Figure 1. Hawaii High
Intensity Drug Trafficking Area
List of Tables
Table 1. Drug-Related Treatment
Admissions to Publicly Funded Facilities in Hawaii, 2004-2008
Strategic Drug Threat Developments
The trafficking and abuse of methamphetamine are the greatest drug threats to
the Hawaii High Intensity Drug Trafficking Area (HIDTA) region. Illicit cannabis
cultivation and subsequent marijuana trafficking and abuse are significant and ever-present
drug threats as well. Mexican drug trafficking organizations (DTOs) pose the greatest
organizational drug threat and are responsible for the transportation and distribution
of most of the ice methamphetamine available in the Hawaii HIDTA region.
The following are significant strategic drug threat developments in the Hawaii
- Mexican DTOs are expanding their ice methamphetamine distribution operations
in the region, leading to increased availability and lower wholesale-level prices
for the drug. Ice methamphetamine is the foremost drug concern in the region
because abuse of the drug is associated with the majority of treatment admissions
and drug-related crime in the state. Increased ice methamphetamine availability
will result in continued high levels of abuse, violent crime, and property crime.
- Illegal cannabis cultivation operations are pervasive throughout the Hawaii
HIDTA region, particularly on the Big Island and Maui. This situation is a serious
drug threat that is driven by the growing demand for high-potency marijuana,
high levels of abuse, and the continued exploitation of Hawaii's medical marijuana
laws by illegal marijuana producers and drug traffickers.
- Restrictions placed upon cannabis eradication efforts on the Big Island
resulted in a 54 percent decrease in the number plants seized at outdoor grows
in the state from 2008 through 2009. In 2008, the Hawaii County Council voted
not to accept federal funding for state and local law enforcement eradication
box in Production section.) Hampered by limited aerial surveillance operations,
law enforcement eradication of outdoor plants is expected to continue to decline
or remain at low levels.
- Over the last year, HIDTA officials have reported increased abuse of other
drugs, including the hallucinogen Salvia divinorum, the stimulant mephedrone
(4-MMC), and synthetic cannabinoids, commonly referred to as "K2" and "Spice."
These "legal highs" are typically sold online and in head shops, smoke shops,
and health food stores. Because these products are relatively new, they have
yet to be regulated, and reliable information about their effects is not available.
The Hawaii State Department of Public Safety, Narcotics Enforcement Division
(NED) requested emergency scheduling of Salvia divinorum in August
2009 and is in the process of introducing similar restrictions for mephedrone
and synthetic cannabinoids.
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622
Tel. (814) 532-4601
FAX (814) 532-4690
Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000
Telephone: (202) 532-4040
FAX (202) 514-4252
End of page.